4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-019028
Chairman and CEO bought 11,600 shares at an average $1.60 ($18,571)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-03-11 | Purchase | +2,500 | $1.64 | $4,100 | 10,477,643 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-12 | Purchase | +3,000 | $1.55 | $4,650 | 10,480,643 | D |
| Niihara Yutaka Chairman and CEO | 2020-03-13 | Purchase | +6,100 | $1.61 | $9,821 | 10,486,743 | D |
| Open-market purchases · 11,600 sh · avg $1.60 · $18,571 | |||||||
Loading xslF345X03/doc4.xml…